Results for National Health Program 9.1 - Spinal cord transplant

Chemical substance: letermovir

ATC code: J05AX18 • Antiinfectives for systemic use | Direct acting antivirals | Other antivirals

Chemical substance: plerixafor

ATC code: L03AX16 • Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants

Chemical substance: plerixafor

ATC code: L03AX16 • Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants

Chemical substance: normal immunoglobulin for intravascular administration

ATC code: J06BA02 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: normal immunoglobulin for intravascular administration

ATC code: J06BA02 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: melphalan

ATC code: L01AA03 • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: tacrolimus

ATC code: L04AD02 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Calcineurin inhibitors

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: normal immunoglobulin for intravascular administration

ATC code: J06BA02 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: normal human immunoglobulin

ATC code: J06BA01 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: normal immunoglobulin for intravascular administration

ATC code: J06BA02 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: normal human immunoglobulin

ATC code: J06BA01 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: normal immunoglobulin for intravascular administration

ATC code: J06BA02 • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Chemical substance: etanercept

ATC code: L04AB01 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Chemical substance: rituximab

ATC code: L01FA01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Chemical substance: isavuconazole

ATC code: J02AC05 • Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Triazole derivatives